A class of investors who allege
The suit, filed in the U.S. District Court for the Southern District of New York, accuses Allergan and its executives of concealing that its silicone-gel breast implants were associated with anaplastic large cell lymphoma. The company’s stock allegedly fell nearly 7% when the products were pulled from European shelves in 2018.
Judge Colleen McMahon previously ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
